Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emerald Health Therapeutics Inc TBQBF


Primary Symbol: EMHTF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.


OTCQB:EMHTF - Post by User

Emerald Health Therapeutics Inc > EMH will be huge
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(9)
•••
Comment by cannhealthon Feb 04, 2019 12:51pm
110 Views
Post# 29315393

RE:RE:RE:RE:RE:RE:EMH will be huge

RE:RE:RE:RE:RE:RE:EMH will be huge
In a word, Robert... Yes. Nemus Labs is at the worldwide cutting edge of research into the Endo-Cannabinoid system and the impacts of THC, CBD, human dosing and delivery methodologies thereof. Avtar expects their research to provide a conveyor of proprietary research, intellectual property and ultimately... patents. Only time will tell how much value EHS and EMH realizes through their funding. Obviously Avtar has examined their research and believes in their potential value.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities